Skip to main content
logo
Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.780
-0.210 (-4.21%)
At close: Sep 11, 2026, 4:00 PM EDT
4.740
-0.040 (-0.83%)
After-hours: Sep 11, 2026, 7:39 PM EDT

Aquestive Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-78.23-83.78-44.14-7.87-54.41-70.54
Depreciation & Amortization
0.540.570.741.372.553.15
Other Amortization
9.551110.711.970.223.73
Stock-Based Compensation
9.377.627.12.694.386.82
Other Operating Activities
12.63-0.03-0.220.85.4625.59
Change in Accounts Receivable
2.54-10.371.09-3.077.35-5.35
Change in Inventory
0.77-0.130.73-0.99-1.74-1.58
Change in Accounts Payable
-3.4619.522.78-1.021.631.23
Change in Unearned Revenue
-1.09-0.57-12.840.9725.043.56
Change in Other Net Operating Assets
2.013.73-1.72-1.23-0.310.41
Operating Cash Flow
-45.37-52.43-35.76-6.38-9.82-32.98
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.58-0.56-0.16-1-1.02-0.91
Sale (Purchase) of Intangibles
-----1.5-
Investing Cash Flow
-0.58-0.56-0.16-1-2.52-0.91

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---31.14--
Long-Term Debt Repaid
--0.03-0.02-51.53--
Net Debt Issued (Repaid)
9.31-0.03-0.02-20.39--
Issuance of Common Stock
87.61103.4684.7217.2613.6230.12
Repurchase of Common Stock
-3.66-0.81-1.1-0.01-0-0.01
Other Financing Activities
-9.36-0.01-0.017.11-2.03-
Financing Cash Flow
83.9102.6283.593.9711.5930.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
37.9549.6247.67-3.4-0.75-3.78

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-45.95-52.99-35.92-7.38-10.84-33.89
Free Cash Flow Growth
------
Free Cash Flow Margin
-84.95%-118.97%-62.40%-14.58%-22.74%-66.67%
Free Cash Flow Per Share
-0.38-0.50-0.41-0.12-0.22-0.89
Levered Free Cash Flow
-26.89-29.24-10.49-16.22-21.29-28.1
Unlevered Free Cash Flow
-26.24-29.54-10.7-13.53-13.73-17.8

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.326.17.14.66.446.44
Cash Income Tax Paid
--0.070.31---
Change in Working Capital
0.7712.18-9.96-5.3431.98-1.73
SEC Filings: 10-K · 10-Q